Publikationen aus dem Jahr 2021
Hoffmeister L, Huebner J, Keinki C, Muenstedt K. Education of non-medical practitioners in Germany-an analysis of course subjects of specialized schools. Wien Med Wochenschr. 2021 Dec 13. English. doi: 10.1007/s10354-021-00896-w. Epub ahead of print. PMID: 34902098
Retzlaff D, Dörfler J, Kutschan S, Freuding M, Büntzel J, Hübner J (2021) The Vitamin E Isoform α-Tocopherol is Not Effective as a Complementary Treatment in Cancer Treatment: A Systematic Review, Nutrition and Cancer, DOI: 10.1080/01635581.2021.2014905
Hochhaus A, Ernst T: TKI discontinuation in CML: how do we make more patients eli gi ble ? How do we increase the chances of a suc cessful treatment - free remission? Hematology 2021, ASH Education Program, 106-112
Fleischmann M, Fischer M, Schnetzke U, Fortner C, Kirkpatrick J, Heidel FH, Hochhaus A, Scholl S. Modulation of FLT3-ITD Localization and Targeting of Distinct Downstream Signaling Pathways as Potential Strategies to Overcome FLT3-Inhibitor Resistance. Cells. 2021 Nov 3;10(11):2992. doi: 10.3390/cells10112992. PMID: 34831215
Josfeld L, Krüger L, Büntzel J, Zomorodbakhsch B, · Hübner J: Self-efficacy in relation to the use of complementary and alternative medicine, lifestyle choices and cancer aetiology. J Cancer Res Clin Oncol (2021). https://doi.org/10.1007/s00432-021-03857-3
Middeke JM, Metzeler KH, Röllig C, Kramer M, Eckardt JN, Stasik S, Greif PA, Spiekermann K, Rothenberg-Thurley M, Krug U, Braess J, Kraemer A, Hochhaus A, Brümmendorf TH, Naumann R, Steffen B, Einsele H, Schaich M, Burchert A, Neubauer A, Görlich D, Sauerland CM, Schaefer-Eckart K, Schliemann C, Krause SW, Hänel M, Frickhofen N, Noppeney R, Kaiser U, Kaufmann M, Kunadt D, Woermann B, Sockel K, von Bonin M, Herold T, Müller-Tidow C, Platzbecker U, Berdel WE, Serve H, Baldus CD, Ehninger G, Schetelig J, Hiddemann W, Bornhäuser M, Stölzel F, Thiede C. Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: Results from a large multicenter study. Blood Adv. 2021 Nov 18:bloodadvances.2021004934. doi: 10.1182/bloodadvances.2021004934. Epub ahead of print. PMID: 34794176
Walter RB, Hochhaus A, Gale RP: Elihu H. Estey, MD: leukemia expert, statistician, and gentle soul (July 15, 1946–October 8, 2021). Leukemia (2021). https://doi.org/10.1038/s41375-021-01467-z
Fleischmann M, Schnetzke U, Hochhaus A, Scholl S. Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives. Cancers (Basel). 2021 Nov 16;13(22):5722. doi: 10.3390/cancers13225722. PMID: 34830877
Vogel J, Zomorodbakhsch B, Thomas Stauch T, Josfeld L, Hübner J: The role of the general practitioner in cancer care in general and with respect to complementary and alternative medicine for patients with cancer. European Journal of Cancer Care, Received: 26 May 2021 Revised: 10 August 2021 Accepted: 4 October 2021, DOI: 10.1111/ecc.13533
O'Hagan Henderson S, Frietsch JJ, Hilgendorf I, Hochhaus A, Köhne CH, Casper J. Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms. J Cancer Res Clin Oncol. 2021 Oct 21. doi: 10.1007/s00432-021-03836-8. Epub ahead of print. PMID: 34674031
Schnoeder TM, Schwarzer A, Jayavelu AK, Hsu CJ, Kirkpatrick J, Döhner K, Perner F, Eifert T, Huber N, Arreba-Tutusaus P, Dolnik A, Assi SA, Nafria M, Jiang L, Dai YT, Chen Z, Chen SJ, Kellaway SG, Ptasinska A, Ng ES, Stanley EG, Elefanty AG, Buschbeck M, Bierhoff H, Brodt S, Matziolis G, Fischer KD, Hochhaus A, Chen CW, Heidenreich O, Mann M, Lane SW, Bullinger L, Ori A, Eyss BV, Bonifer C, Heidel F. PLCG1 is required for AML1-ETO leukemia stem cell self-renewal. Blood. 2021 Oct 25:blood.2021012778. doi: 10.1182/blood.2021012778. Epub ahead of print. PMID: 34695195
Hübner, J., Stoll, C. & Keinki, C. Immunstimulanzien aus der Naturheilkunde und ihr Einsatz bei Neoplasien. Onkologe 27, 1125–1130 (2021). https://doi.org/10.1007/s00761-021-01040-4
O'Hagan Henderson S, Frietsch JJ, Hilgendorf I, Hochhaus A, Köhne CH, Casper J. Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms. J Cancer Res Clin Oncol. 2021 Oct 21. doi: 10.1007/s00432-021-03836-8. Epub ahead of print. PMID: 34674031
Hübner, J., Stoll, C. & Keinki, C. Immunstimulanzien aus der Naturheilkunde und ihr Einsatz bei Neoplasien. Onkologe (2021). https://doi.org/10.1007/s00761-021-01040-4
Hübner J, Beckmann M , Follmann M, Nothacker M, Prott FJ, Wörmann B: Komplementärmedizin in der Behandlung von onkologisch erkrankten Patienten; Dtsch Arztebl Int 2021; 118: 654-9; DOI: 10.3238/arztebl.m2021.0277
Gale RP, Hochhaus A, Cross NCP, Harrison CJ: HGNC nomenclature for fusion genes. Leukemia (2021). https://doi.org/10.1038/s41375-021-01437-5
Mühleck, R., Scholl, S., Hilgendorf, I. et al. Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy. J Cancer Res Clin Oncol 148, 2539–2548 (2022). https://doi.org/10.1007/s00432-021-03821-1
Reuken PA, Rüthrich MM, Hochhaus A, Hammersen J, Bauer M, La Rosée P, La Rosée F, Stallmach A: The impact of specific cytokine directed treatment on severe COVID-19. Leukemia. 2021 Sep 7:1–3. doi: 10.1038/s41375-021-01411-1. Epub ahead of print. PMID: 34493799; PMCID: PMC8422045.
Döhner H, Malcovati L, Ossenkoppele GJ, Hochhaus A, Maria Vannucchi A, Bullinger L, Cervantes F, Craddock C, de Witte T, Döhner K, Dombret H, Fenaux P, Geissler J, Germing U, Guilhot F, Harrison C, Hellström-Lindberg E, Passamonti F, Sierra J, Skoda R, Wierzbowska A. The EHA Research Roadmap: Malignant Myeloid Diseases. Hemasphere. 2021 Aug 26;5(9):e635. doi: 10.1097/HS9.0000000000000635. PMID: 34476345; PMCID: PMC8389885
Heinicke T, Krahl R, Kahl C, Cross M, Scholl S, Wolf HH, Hähling D, Hegenbart U, Peter N, Schulze A, Florschütz A, Schmidt V, Reifenrath K, Zojer N, Junghanss C, Sayer HG, Maschmeyer G, Späth C, Hochhaus A, Fischer T, Al-Ali HK, Niederwieser D. Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials. Ann Hematol. 2021 Sep;100(9):2387-2398. doi: 10.1007/s00277-021-04565-1. Epub 2021 Jul 7. PMID: 34232360
O'Hagan Henderson S, Glaser A, Frietsch JJ, Hochhaus A, Hilgendorf I. The incidental discovery of a constitutional trisomy 21 mosaicism in an adult female with myelodysplastic/myeloproliferative neoplasm. Ann Hematol. 2021 Sep 1. doi: 10.1007/s00277-021-04655-0. Epub ahead of print. PMID: 34471943
Stasik S, Eckardt JN, Kramer M, Röllig C, Krämer A, Scholl S, Hochhaus A, Crysandt M, Brümmendorf TH, Naumann R, Steffen B, Kunzmann V, Einsele H, Schaich M, Burchert A, Neubauer A, Schäfer-Eckart K, Schliemann C, Krause S, Herbst R, Hänel M, Frickhofen N, Noppeney R, Kaiser U, Baldus CD, Kaufmann M, Rácil Z, Platzbecker U, Berdel WE, Mayer J, Serve H, Müller-Tidow C, Ehninger G, Bornhäuser M, Schetelig J, Middeke JM, Thiede C; Study Alliance Leukemia (SAL). Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia. Blood Adv. 2021 Sep 14;5(17):3279-3289. doi: 10.1182/bloodadvances.2021004631. PMID: 34459887
Hübner J, Münstedt K, Micke O, Prott FJ,Schmidt T, Büntzel J: Zentrale Empfehlungen und Statements der S3-Leitlinie zur komplementären Medizin für Patient*innen mit onkologischen Erkrankungen – Teil 2. Onkologe 27, 917–921 (2021). https://doi.org/10.1007/s00761-021-00990-z
Réa D, Mauro MJ, Boquimpani C, Minami Y, Lomaia E, Voloshin S, Turkina A, Kim DW, Apperley JF, Abdo A, Fogliatto LM, Kim DDH, le Coutre P, Saussele S, Annunziata M, Hughes TP, Chaudhri N, Sasaki K, Chee L, García-Gutiérrez V, Cortes JE, Aimone P, Allepuz A, Quenet S, Bédoucha V, Hochhaus A. A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs. Blood. 2021 Nov 25;138(21):2031-2041. doi: 10.1182/blood.2020009984. PMID: 34407542
Cortes J, Apperley JF, Lomaia E, Moiraghi B, Undurraga MS, Pavlovsky C, Chuah C, Sacha T, Lipton JH, Schiffer CA, McCloskey J, Hochhaus A, Rousselot P, Rosti G, de Lavallade H, Turkina A, Rojas C, Arthur C, Maness LJ, Talpaz M, Mauro MJ, Hall T, Lu V, Srivastava S, Deininger MW. Ponatinib Dose-Ranging Study in Chronic-Phase Chronic Myeloid Leukemia: A Randomized, Open-Label Phase 2 Clinical Trial. Blood. 2021 Aug 18:blood.2021012082. doi: 10.1182/blood.2021012082. Epub ahead of print. PMID: 34407543
Hoppe C, Freuding M, Büntzel J, Münstedt K, Hübner J: Clinical efficacy and safety of oral and intravenous vitamin C use in patients with malignant diseases. J Cancer Res Clin Oncol (2021). https://doi.org/10.1007/s00432-021-03759-4
Schnetzke U: Aggressives B-Zell-Lymphom: Registerstudien bestätigen die Wirksamkeit von CAR-T-Zell-Therapien. Kompass Onkol 2021. doi: 10.1159/000518702
Taube F, Georgi JA, Kramer M, Stasik S, Middeke JM, Röllig C, Krug U, Krämer A, Scholl S, Hochhaus A, Brümmendorf TH, Naumann R, Petzold A, Mulet-Lazaro R, Valk PJM, Steffen B, Einsele H, Schaich M, Burchert A, Neubauer A, Schäfer-Eckart K, Schliemann C, Krause SW, Hänel M, Noppeney R, Kaiser U, Baldus C, Kaufmann M, Herold S, Stölzel F, Sockel K, von Bonin M, Müller-Tidow C, Platzbecker U, Berdel WE, Serve H, Ehninger G, Bornhäuser M, Schetelig J, Thiede C. CEBPA Mutations in 4708 Patients with Acute Myeloid Leukemia - Differential Impact of bZIP and TAD Mutations on Outcome. Blood. 2021 Jul 28:blood.2020009680. doi: 10.1182/blood.2020009680. Epub ahead of print. PMID: 34320176
Ruhe J, Schnetzke U, Kentouche K, Prims F, Baier M, Herfurth K, Schlosser M, Busch M, Hochhaus A, Wolf G. Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine. Ann Hematol. 2021 Jul 26. doi: 10.1007/s00277-021-04584-y. Epub ahead of print. PMID: 34309715
Fleischmann M, Schnetzke U, Frietsch JJ, Sayer HG, Schrenk K, Hammersen J, Glaser A, Hilgendorf I, Hochhaus A, Scholl S. Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia. J Cancer Res Clin Oncol. 2021 Jul 23. doi: 10.1007/s00432-021-03733-0. Epub ahead of print. PMID: 34297206
Hübner J, Münstedt K, Micke O, Prott FJ, Schmidt T, Büntzel J: Zentrale Empfehlungen und Statements der S3-Leitlinie zur komplementären Medizin für Patient*innen mit onkologischen Erkrankungen – Teil 1. Onkologe 27, 795–801 (2021). https://doi.org/10.1007/s00761-021-00989-6
Gericke M., Geitel, Jörke C, Clement JH, Heinze T: Reactive Nanoparticles Derived from Polysaccharide Phenyl Carbonates. Molecules 2021, 26, 4026. https://doi.org/10.3390/molecules26134026
Hübner J, Mücke R, Micke O, Keinki C: Komplementärmedizin in der Uroonkologie. Urologe 60, 953–962 (2021). https://doi.org/10.1007/s00120-021-01584-8
Gremmler L, Kutschan S, Dörfler J, Büntzel J, Büntzel J, Hübner J. Proteolytic Enzyme Therapy in Complementary Oncology: A Systematic Review. Anticancer Res. 2021 Jul;41(7):3213-3232. doi: 10.21873/anticanres.15108. Epub 2021 Jul 5. PMID: 34230116
Krüger WH, Hirt C, Basara N, Sayer HG, Behre G, Fischer T, Grobe N, Maschmeyer G, Niederwieser D, Dölken G. Allogeneic stem cell transplantation for mantle cell lymphoma--final report from the prospective trials of the East German Study Group Haematology/Oncology (OSHO). Ann Hematol. 2014 Sep;93(9):1587-97. doi: 10.1007/s00277-014-2087-z. Epub 2014 Apr 30. PMID: 24782119
Wolf CPJG, Rachow T, Ernst T, Hochhaus A, Zomorodbakhsch B, Foller S, Rengsberger M, Hartmann M, Huebner J. Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment. J Cancer Res Clin Oncol. 2021 Jul 6. doi: 10.1007/s00432-021-03675-7. Epub ahead of print. PMID: 34228225
von Lilienfeld-Toal M, Rieger C, Giesen N. et al. Impfung gegen SARS-CoV-2 bei Krebspatienten. Onkologe 27, 691–696 (2021). https://doi.org/10.1007/s00761-021-00972-1
Mickoleit F, Jörke C, Geimer S, Maier D, Müller JP, Demut J, Gräfe C, Schüler D, Clement JH. 2021. Biocompatibility, uptake and subcellular localization of bacterial magnetosomes in mammalian cells. Nanoscale Advances: https://doi.org/10.1039/D0NA01086C
Middeke JM, Teipel R, Röllig C, Stasik S, Zebisch A, Sill H, Kramer M, Scholl S, Hochhaus A, Jost E, Brümmendorf TH, Naumann R, Steffen B, Serve H, Altmann H, Kunzmann V, Einsele H, Parmentier S, Schaich M, Burchert A, Neubauer A, Schliemann C, Berdel WE, Sockel K, Stölzel F, Platzbecker U, Ehninger G, Bornhäuser M, Schetelig J, Thiede C; Study Alliance Leukemia (SAL). Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of TP53 mutations - a registry based analysis. Leuk Lymphoma. 2021 Jun;62(6):1432-1440. doi: 10.1080/10428194.2020.1864354. Epub 2021 Jan 5. PMID: 33399480
Petr Vitek P, Koscielny S, Büssing A, Hübner J, Büntzel J. Religiosität und Spiritualität als Ressourcen in der Betreuung von Patienten mit Kopf-Hals-Tumoren; Laryngorhinootologie 2021; DOI: 10.1055/a-1516-4589
Büssing A, Recchia DR, Hübner J, Walter S, Büntzel J, Büntzel J. Tumor patients' fears and worries and perceived changes of specific attitudes, perceptions and behaviors due to the COVID-19 pandemic are still relevant. J Cancer Res Clin Oncol. 2021 Jun;147(6):1673-1683. doi: 10.1007/s00432-021-03573-y. Epub 2021 Mar 6. PMID: 33675401; PMCID: PMC7936591
Welter S, Keinki C, Ahmadi E, Huebner J. Lay Etiology, Self-Efficacy and Patient Activation Among Cancer Patients. Cancer Invest. 2021 Mar;39(3):219-228. doi: 10.1080/07357907.2021.1878528. Epub 2021 Feb 2. PMID: 33475001
Baier L, Hübner J, Kerschbaum E, Erickson N. Krebsdiäten: patientenzentrierte Kommunikationsstrategien; Onkologe 2021; 27:148–153
Männle H, Momm F, Hübner J, Münstedt K. Do breast cancer patients adapt CAM methods according to the therapeutic situation? Complement Ther Clin Pract. 2021 May;43:101305. doi: 10.1016/j.ctcp.2021.101305. Epub 2021 Jan 23. PMID: 33516058
Giesen N, Sprute R, Rüthrich M, Khodamoradi Y, Mellinghoff SC, Beutel G, Lueck C, Koldehoff M, Hentrich M, Sandherr M, von Bergwelt-Baildon M, Wolf HH, Hirsch HH, Wörmann B, Cornely OA, Köhler P, Schalk E, von Lilienfeld-Toal M; COVID-19 guideline panel of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). 2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy. Eur J Cancer. 2021 Apr;147:154-160. doi: 10.1016/j.ejca.2021.01.033. Epub 2021 Feb 10. PMID: 33676266; PMCID: PMC7874914
Schmoll HJ; Lindner LH, Reichardt P, Heißner K, Kopp HG, Kessler T, Mayer-Steinacker R, Rüssel J, Egerer G, Crysandt M, Kasper B, Niederwieser D, Kunitz A, MD12; Eigendorff E, Petersen I, Steighardt J, Cygon F, Meinert F, Stein A: Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial. JAMA Oncol. 2021;7(2):255-262. doi:10.1001/jamaoncol.2020.6564
Eyre TA, Caillard S, Finel H, Boumendil A, Kothari J, Zimmermann H, Trappe RU, De Wilde V, Tholouli E, Kanfer E, Broom A, Damaj G, Bargetzi M, Kozák T, Hilgendorf I, Crawley C, Kerre T, Trněný M, Bachy E, Robinson S, Montoto S. Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMT. Bone Marrow Transplant. 2021 Apr 16. doi: 10.1038/s41409-021-01270-5. Epub ahead of print. PMID: 33864020
Schrickel L, Heidel FH, Sadjadian P, Becker T, Kolatzki V, Hochhaus A, Griesshammer M, Wille K; German Study Group MPN, GSG-MPN. Interferon alpha for essential thrombocythemia during 34 high-risk pregnancies: outcome and safety. J Cancer Res Clin Oncol. 2021 May;147(5):1481-1491. doi: 10.1007/s00432-020-03430-4. Epub 2020 Nov 2. PMID: 33140210
Graf La Rosée, H.-C. Bremer, F. La Rosée, P. Mohm, A. Hochhaus, I. Gehrke, B. Kumle, A. Benzing & S. Russo: Interdisziplinäres COVID-Board bei SARS-CoV-2-getriggerter hyperferritinämischer Inflammation. MedKlin IntensivmedNotfmed2021, 116:138–145, https://doi.org/10.1007/s00063-020-00750-8
Brioli A, Manz K, Pfirrmann M, Hänel M, Schwarzer AC, Prange-Krex G, Fabisch C, Knop S, Illmer T, Krammer-Steiner B, Hochhaus A, von Lilienfeld-Toal M, Mügge LO. Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN). J Cancer Res Clin Oncol. 2020 Mar;146(3):749-759. doi: 10.1007/s00432-019-03101-z. Epub 2019 Dec 2. PMID: 31788741
Büntzel J, Walter S, Hellmund H, Klein M, Hübner J, Vitek P, Büntzel J, Koscielny S, Sesterhenn AM, Büssing A. Auswirkungen der COVID-19-Pandemie auf die Versorgung von HNO-Tumoren – die Patientenperspektive [Oncology Services for Patients with Head Neck Cancer during Corona-Times - Patients' Perspective]. Laryngorhinootologie. 2021 Feb;100(2):104-110. German. doi: 10.1055/a-1327-4234. Epub 2020 Dec 14. PMID: 33316831
Ciarlo G, Ahmadi E, Welter S, Hübner J. Factors influencing the usage of complementary and alternative medicine by patients with cancer. Complement Ther Clin Pract. 2021 Apr 15;44:101389. doi: 10.1016/j.ctcp.2021.101389. Epub ahead of print. PMID: 33932731
Christiansen N, Walter S, Zomorodbakhsch B, Sartakhti EA, Hübner J. Assessment of Self-Efficacy as a Way to Help Identify Cancer Patients Who Might Benefit from Self-Help Group Attendance? Cancer Invest. 2021 Feb;39(2):133-143. doi: 10.1080/07357907.2020.1867996. Epub 2021 Jan 6. PMID: 33356618
Josfeld L, Keinki C, Pammer C, Zomorodbakhsch B, Hübner J. Cancer patients' perspective on shared decision-making and decision aids in oncology. J Cancer Res Clin Oncol. 2021 Jun;147(6):1725-1732. doi: 10.1007/s00432-021-03579-6. Epub 2021 Mar 7. PMID: 33682014; PMCID: PMC8076112
Morkramer L, Geitner M, Boeger D, Buentzel J, · Kaftan H, · Mueller AH,·Ernst T, · Guntinas‑Lichius O: Systemic therapy for recurrent and/or metastatic head and neck cancer: a population-based healthcare research study in Thuringia, Germany. J Cancer Res Clin Oncol (2021). https://doi.org/10.1007/s00432-021-03535-4
Büntzel J, Micke O, Klein M, Büntzel J, Walter S, Keinki C, Huebner J. Take care or "German Angst"? Lessons from cancer care during COVID-19 pandemic in spring 2020. J Cancer Res Clin Oncol (2021) 147:2093–2105. doi: 10.1007/s00432-020-03492-4. Epub ahead of print. PMID: 33387036; PMCID: PMC7776312
Römer M, Dörfler J, Huebner J. The use of ketogenic diets in cancer patients: a systematic review. Clin Exp Med. 2021 Apr 3. doi: 10.1007/s10238-021-00710-2. Epub ahead of print. PMID: 33813635
Hoppe C, Kutschan S, Dörfler J, Büntzel J, Büntzel J, Huebner J. Zinc as a complementary treatment for cancer patients: a systematic review. Clin Exp Med. 2021 May;21(2):297-313. doi: 10.1007/s10238-020-00677-6. Epub 2021 Jan 26. PMID: 33496846; PMCID: PMC8053661
Keinki C, Momberg A, Clauß K, Bozkurt G, Hertel E, Freuding M, Josfeld L, Huebner J. Effect of question prompt lists for cancer patients on communication and mental health outcomes-A systematic review. Patient Educ Couns. 2021 Jan 15:S0738-3991(21)00039-2. doi: 10.1016/j.pec.2021.01.012. Epub ahead of print. PMID: 33593643
Wiese F, Kutschan S, Doerfler J, Mathies V, Buentzel J, Buentzel J, Huebner J. Green tea and green tea extract in oncological treatment: A systematic review. Int J Vitam Nutr Res. 2021 Feb 17:1-13. doi: 10.1024/0300-9831/a000698. Epub ahead of print. PMID: 33593083
Thieser S, Dörfler J, Rudolph I, Wozniak T, Schmidt T, Hübner J. Influence of ballroom dancing on fatigue, body image, self-efficacy, and endurance of cancer patients and their partners. Med Oncol. 2021 Jan 28;38(2):15. doi: 10.1007/s12032-021-01459-0. PMID: 33507443; PMCID: PMC7843482
Sonneborn-Papakostopoulos M, Dubois C, Mathies V, Heß M, Erickson N, Ernst T, Huebner J. Quality of life, symptoms and dietary habits in oncology outpatients with malnutrition: A cross-sectional study. Med Oncol. 2021 Feb 4;38(2):20. doi: 10.1007/s12032-021-01460-7. PMID: 33543336; PMCID: PMC7862192
Eckardt JN, Stasik S, Kramer M, Röllig C, Krämer A, Scholl S, Hochhaus A, Crysandt M, Brümmendorf TH, Naumann R, Steffen B, Kunzmann V, Einsele H, Schaich M, Burchert A, Neubauer A, Schäfer-Eckart K, Schliemann C, Krause SW, Herbst R, Hänel M, Frickhofen N, Noppeney R, Kaiser U, Baldus CD, Kaufmann M, Rácil Z, Platzbecker U, Berdel WE, Mayer J, Serve H, Müller-Tidow C, Ehninger G, Stölzel F, Kroschinsky F, Schetelig J, Bornhäuser M, Thiede C, Middeke JM. Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia. Cancers (Basel). 2021 Apr 26;13(9):2095. doi: 10.3390/cancers13092095. PMID: 33926021
Wolf CPJG, Rachow T, Ernst T, Hochhaus A, Zomorodbakhsch B, Foller S, Rengsberger M, Hartmann M, Hübner J. Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements. J Cancer Res Clin Oncol. 2021 Apr 17. doi: 10.1007/s00432-021-03625-3. Epub ahead of print. PMID: 33864520
Dufter SA, Hübner J, Ahmadi E, Zomorodbakhsch B. Traits of cancer patients and CAM usage. J Cancer Res Clin Oncol. 2021 Dec;147(12):3685-3692. doi: 10.1007/s00432-021-03605-7. Epub 2021 Apr 2. PMID: 33811274
Ernst P, Heidel FH. Molecular Mechanisms of Senescence and Implications for the Treatment of Myeloid Malignancies. Cancers (Basel). 2021 Feb 4;13(4):612. doi: 10.3390/cancers13040612. PMID: 33557090; PMCID: PMC7913823
Palandri F, Palumbo GA, Elli EM, Polverelli N, Benevolo G, Martino B, Abruzzese E, Tiribelli M, Tieghi A, Latagliata R, Cavazzini F, Bergamaschi M, Binotto G, Crugnola M, Isidori A, Caocci G, Heidel F, Pugliese N, Bosi C, Bartoletti D, Auteri G, Cattaneo D, Scaffidi L, Trawinska MM, Stella R, Ciantia F, Pane F, Cuneo A, Krampera M, Semenzato G, Lemoli RM, Iurlo A, Vianelli N, Cavo M, Breccia M, Bonifacio M. Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis. Blood Cancer J. 2021 Jan 7;11(1):4. doi: 10.1038/s41408-020-00392-1. PMID: 33414394; PMCID: PMC7791065
Polverelli N, Elli EM, Abruzzese E, Palumbo GA, Benevolo G, Tiribelli M, Bonifacio M, Tieghi A, Caocci G, D'Adda M, Bergamaschi M, Binotto G, Heidel FH, Cavazzini F, Crugnola M, Pugliese N, Bosi C, Isidori A, Bartoletti D, Auteri G, Latagliata R, Gandolfi L, Martino B, Scaffidi L, Cattaneo D, D'Amore F, Trawinska MM, Stella R, Markovic U, Catani L, Pane F, Cuneo A, Krampera M, Semenzato G, Lemoli RM, Vianelli N, Breccia M, Russo D, Cavo M, Iurlo A, Palandri F. Second primary malignancy in myelofibrosis patients treated with ruxolitinib. Br J Haematol. 2020 Nov 21. doi: 10.1111/bjh.17192. Epub ahead of print. PMID: 33222197
Benevolo G, Elli EM, Bartoletti D, Latagliata R, Tiribelli M, Heidel FH, Cavazzini F, Bonifacio M, Crugnola M, Binotto G, D'Addio A, Tieghi A, Bergamaschi M, Caocci G, Polverelli N, Bossi E, Auteri G, Carmosino I, Catani L, Cuneo A, Krampera M, Lanza F, Lemoli RM, Vianelli N, Breccia M, Palumbo GA, Cavo M, Palandri F. Impact of comorbidities and body mass index on the outcome of polycythemia vera patients. Hematol Oncol. 2021 Feb 15. doi: 10.1002/hon.2843. Epub ahead of print. PMID: 33590502
Heidel FH, Platzbecker U. The Genomic Landscape of Myeloid Malignancies: Options for Pan-myeloid Therapies? Hemasphere. 2021 Feb 10;5(3):e537. doi: 10.1097/HS9.0000000000000537. PMID: 33604515; PMCID: PMC7886402
Palandri F, Tiribelli M, Breccia M, Bartoletti D, Elli EM, Benevolo G, Martino B, Cavazzini F, Tieghi A, Iurlo A, Abruzzese E, Pugliese N, Binotto G, Caocci G, Auteri G, Cattaneo D, Trawinska MM, Stella R, Scaffidi L, Polverelli N, Micucci G, Masselli E, Crugnola M, Bosi C, Heidel FH, Latagliata R, Pane F, Cuneo A, Krampera M, Semenzato G, Lemoli RM, Cavo M, Vianelli N, Bonifacio M, Palumbo GA. Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome. Cancer. 2021 Apr 1. doi: 10.1002/cncr.33541. Epub ahead of print. PMID: 33794557
Loncarevic IF, Toepfer S, Hubold S, Klingner S, Kanitz L, Ellinger T, Steinmetzer K, Ernst T, Hochhaus A, Ermantraut E. Ultra-precise quantification of mRNA targets across a broad dynamic range with nanoreactor beads. PLoS One. 2021 Mar 18;16(3):e0242529. doi: 10.1371/journal.pone.0242529. PMID: 33735175
Frietsch JJ, Hunstig F, Wittke C, Junghanss C, Franiel T, Scholl S, Hochhaus A, Hilgendorf I. Extra-medullary recurrence of myeloid leukemia as myeloid sarcoma after allogeneic stem cell transplantation: impact of conditioning intensity. Bone Marrow Transplant. 2021 Jan;56(1):101-109. doi: 10.1038/s41409-020-0984-4. Epub 2020 Jun 30. PMID: 32606455; PMCID: PMC7796857
Hinze A, Rinke J, Hochhaus A, Ernst T. Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation. Ann Hematol. 2021 Feb;100(2):581-584. doi: 10.1007/s00277-020-04152-w. Epub 2020 Jun 23. PMID: 32577845; PMCID: PMC7817602
Pulewka K, Strauss B, Hochhaus A, Hilgendorf I. Clinical, social, and psycho-oncological needs of adolescents and young adults (AYA) versus older patients following hematopoietic stem cell transplantation. J Cancer Res Clin Oncol. 2021 Apr;147(4):1239-1246. doi: 10.1007/s00432-020-03419-z. Epub 2020 Oct 14. PMID: 33052515
Radich JP, Hochhaus A, Masszi T. et al. Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial. Leukemia (2021). https://doi.org/10.1038/s41375-021-01205-5
Schäfer V, White HE, Gerrard G, Möbius S, Saussele S, Franke GN, Mahon FX, Talmaci R, Colomer D, Soverini S, Machova Polakova K, Cross NCP, Hochhaus A, Ernst T. Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network. J Cancer Res Clin Oncol. 2021 Mar 7. doi: 10.1007/s00432-021-03569-8. Epub ahead of print. PMID: 33677711
Richter F, Mapfumo P, Martin L, Solomun JI, Hausig F, Frietsch JJ, Ernst T, Hoeppener S, Brendel JC & Traeger A: Improved gene delivery to K-562 leukemia cells by lipoic acid modified block copolymer micelles. J Nanobiotechnol 19, 70 (2021). https://doi.org/10.1186/s12951-021-00801-y
Wagner-Drouet E, Teschner D, Wolschke C, Schäfer-Eckart K, Gärtner J, Mielke S, Schreder M, Kobbe G, Hilgendorf I, Klein S et al. Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-ELISpot Assay after Hematopoietic Stem Cell Transplantation. Diagnostics 2021, 11, 312. https://doi.org/10.3390/diagnostics11020312
Schrenk KG: Systemtherapie von Sarkomen. Ärzteblatt THÜRINGEN · 2/2021, 13-15
Vogt M, Langenberg J, Schüle S, Aschenbach R, Schrenk KG, Hofmann GO: Die strukturierte Tumornachsorge bei Sarkomen – zehn Jahre nach der Therapie. Ärzteblatt THÜRINGEN · 2/2021, 16-19
Henn S, Hübner J, Schäfer S, Uhde A, Zorn A: Erfassung regionaler Unterschiede in der Krebsprävention in Thüringen: der Krebspräventionsinfrastruktur-Index. Forum 2021 · 36:67–68, https://doi.org/10.1007/s12312-020-00877-x, Online publiziert: 11. Januar 2021 © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2021
Rachow T, Schiffl H, Lang SM. Risk of lung cancer and renin-angiotensin blockade: a concise review. J Cancer Res Clin Oncol. 2021 Jan;147(1):195-204. doi: 10.1007/s00432-020-03445-x. Epub 2020 Nov 24. PMID: 33231730; PMCID: PMC7684567
Brioli A., Hochhaus A. (2021) Immune Checkpoint Blockade. In: Offermanns S., Rosenthal W. (eds) Encyclopedia of Molecular Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-030-21573-6_10053-1
Voigt M, Sinn K, Malouhi A, Gecks T, Zinke J, Hilgendorf I, Scholl S, Hochhaus A, Schnetzke U. HHV-6 encephalitis in a non-transplanted adult acute myeloid leukemia patient. Ann Hematol. 2021 Jan 14. doi: 10.1007/s00277-021-04409-y. Epub ahead of print. PMID: 33443593
Lennart J. Gresing, Patricia Radon, Ralf P. Friedrich, Diana Zahn, Martin Raasch, Alexander S. Mosig, Silvio Dutz, Christoph Alexiou, Frank Wiekhorst, Andreas Hochhaus, Joachim H. Clement: Negatively charged magnetic nanoparticles pass the blood-placenta barrier under continuous flow conditions in a time-dependent manner. Journal of Magnetism and Magnetic Materials, Volume 521, Part 2, 2021, 167535, ISSN 0304-8853, https://doi.org/10.1016/j.jmmm.2020.167535. (http://www.sciencedirect.com/science/article/pii/S0304885320325026)
Schüle S, Gampe M, Lindig U, Pelli M, Settmacher U: Gastrointestinale Stromatumore (GIST). ÄRZTEBLAT 26 T THÜRINGEN · 1/2021, 25-27
Kantarjian HM, Hughes TP, Larson RA, Kim DW, Issaragrisil S, le Coutre P, Etienne G, Boquimpani C, Pasquini R, Clark RE, Viviane Dubruille, Flinn IW, Kyrcz-Krzemien S, Medras E, Zanichelli M, Bendit I, Cacciatore S, Titorenko K, Aimone P, Saglio G, Hochhaus A: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis. Leukemia (2021). https://doi.org/10.1038/s41375-020-01111-2
Middeke JM, Teipel R, Röllig C, Stasik S, Zebisch A, Sill H, Kramer M, Scholl S, Hochhaus A, Jost E, Brümmendorf TH, Naumann R, Steffen B, Serve H, Altmann H, Kunzmann V, Einsele H, Parmentier S, Schaich M, Burchert A, Neubauer A, Schliemann C, Berdel WE, Sockel K, Stölzel F, Platzbecker U, Ehninger G, Bornhäuser M, Schetelig J, Thiede C; Study Alliance Leukemia (SAL). Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of TP53 mutations - a registry based analysis. Leuk Lymphoma. 2021 Jan 5:1-15. doi: 10.1080/10428194.2020.1864354. Epub ahead of print. PMID: 33399480.